Origin Company, Limited (TYO:6513)
Japan · Delayed Price · Currency is JPY 1,073.00
-2.00 (-0.19%)
Aug 8, 2025, 3:19 PM JST
Theseus Pharmaceuticals Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 480 | -985 | 1,269 | 3,009 | -602 | Upgrade |
Depreciation & Amortization | 964 | 971 | 986 | 1,018 | 1,162 | Upgrade |
Loss (Gain) From Sale of Assets | 17 | 51 | 69 | -207 | 103 | Upgrade |
Loss (Gain) on Equity Investments | -35 | 22 | -5 | -5 | 2 | Upgrade |
Other Operating Activities | -381 | -572 | -474 | -464 | -482 | Upgrade |
Change in Accounts Receivable | 343 | -364 | 1,563 | -1,271 | 313 | Upgrade |
Change in Inventory | 350 | -117 | 231 | -2,231 | 796 | Upgrade |
Change in Accounts Payable | -1,607 | 683 | -1,864 | 2,082 | -681 | Upgrade |
Change in Other Net Operating Assets | -534 | 322 | -3 | -276 | -1,099 | Upgrade |
Operating Cash Flow | -403 | 11 | 1,772 | 1,655 | -488 | Upgrade |
Operating Cash Flow Growth | - | -99.38% | 7.07% | - | - | Upgrade |
Capital Expenditures | -1,873 | -659 | -697 | -477 | -462 | Upgrade |
Sale of Property, Plant & Equipment | -52 | -62 | -27 | 314 | 135 | Upgrade |
Divestitures | 8 | - | - | - | - | Upgrade |
Sale (Purchase) of Intangibles | -66 | -45 | -62 | -23 | -50 | Upgrade |
Investment in Securities | 500 | 1,022 | -641 | 1,451 | 327 | Upgrade |
Other Investing Activities | 7 | -56 | -37 | 491 | 141 | Upgrade |
Investing Cash Flow | -1,476 | 200 | -1,464 | 1,756 | 91 | Upgrade |
Short-Term Debt Issued | 700 | - | - | - | - | Upgrade |
Long-Term Debt Issued | - | 2,500 | 50 | 100 | 100 | Upgrade |
Total Debt Issued | 700 | 2,500 | 50 | 100 | 100 | Upgrade |
Long-Term Debt Repaid | -574 | -554 | -579 | -575 | -575 | Upgrade |
Total Debt Repaid | -574 | -554 | -579 | -575 | -575 | Upgrade |
Net Debt Issued (Repaid) | 126 | 1,946 | -529 | -475 | -475 | Upgrade |
Issuance of Common Stock | - | - | - | - | 2 | Upgrade |
Repurchase of Common Stock | -422 | -372 | -392 | - | -201 | Upgrade |
Dividends Paid | -193 | -206 | -400 | -212 | -172 | Upgrade |
Other Financing Activities | -298 | -348 | -561 | -447 | -479 | Upgrade |
Financing Cash Flow | -787 | 1,020 | -1,882 | -1,134 | -1,325 | Upgrade |
Foreign Exchange Rate Adjustments | 135 | 224 | 395 | 456 | 32 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | 1 | 2 | - | 1 | Upgrade |
Net Cash Flow | -2,531 | 1,456 | -1,177 | 2,733 | -1,689 | Upgrade |
Free Cash Flow | -2,276 | -648 | 1,075 | 1,178 | -950 | Upgrade |
Free Cash Flow Growth | - | - | -8.74% | - | - | Upgrade |
Free Cash Flow Margin | -7.90% | -2.30% | 3.36% | 3.64% | -3.66% | Upgrade |
Free Cash Flow Per Share | -421.27 | -112.54 | 178.53 | 189.80 | -151.74 | Upgrade |
Cash Interest Paid | 23 | 12 | 6 | 10 | 14 | Upgrade |
Cash Income Tax Paid | 384 | 523 | 479 | 461 | 285 | Upgrade |
Levered Free Cash Flow | -3,092 | 212.5 | 778 | 1,287 | 621.25 | Upgrade |
Unlevered Free Cash Flow | -3,078 | 220.63 | 781.75 | 1,294 | 630 | Upgrade |
Change in Net Working Capital | 1,949 | -318 | -196 | 555 | -545 | Upgrade |
Updated Feb 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.